{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:07:45Z","timestamp":1787317665510,"version":"build-2736575974"},"reference-count":45,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009131","name":"Swiss Agency for Development and Cooperation","doi-asserted-by":"crossref","award":["Phase 7F-07381.02.01, Contract No. 81035072"],"award-info":[{"award-number":["Phase 7F-07381.02.01, Contract No. 81035072"]}],"id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Antimicrobial resistance (AMR) is a major threat in sub-Saharan Africa (SSA), but assessments of antimicrobial consumption (AMC) are limited. This study aimed to investigate regional AMC and resistance patterns in a representative area of Tanzania and to introduce a method for determining AMC in low-resource settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study using prescription data collected over 5 years (2013\u20132017) from multiple hospitals and selected primary health facilities in the Dodoma Region of Tanzania. The study employed the WHO\u2019s Anatomical Therapeutic Chemical (ATC) classification and Daily Defined Dose (DDD) methodology to quantify antimicrobial use. Outpatient prescription records that met our inclusion criteria were analysed, while incomplete records were excluded. Sensitivity testing for frequently prescribed antimicrobials was performed against representative gram-negative and gram-positive bacteria, with resistance expressed as minimum inhibitory concentrations and resistance percentages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and participants<\/jats:title>\n                    <jats:p>This study was conducted across several high-volume healthcare facilities in the Dodoma Region, encompassing both hospital and primary care settings. The dataset comprises outpatient prescription records from these facilities, representing a significant proportion of the regional healthcare usage. The selected facilities were chosen based on their substantial catchment populations to maximise data volume and relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>The primary outcome measure was the DDD per 1000 inhabitants per day (DID) for various antimicrobial classes. Secondary outcomes included the prevalence of specific drugs, such as amoxicillin and erythromycin, and their corresponding resistance profiles. Resistance data were quantitatively analysed, with particular attention given to penicillinase-sensitive penicillins and their resistance rates among gram-negative and Gram-positive bacteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Analysis revealed that single penicillins, particularly amoxicillin, dominated prescriptions, accounting for 25% to 60% of hospitals and 13% to 29% of primary health centres. Erythromycin was prescribed in 9.4% to 25.1% of cases across facilities. The overall AMC in the region ranged from 36.7 to 50.2 DID during the study period, with consumption patterns showing an initial increase of 4.3% from 2013 to 2014, a subsequent 29.0% decrease from 2014 to 2015, followed by a 34.1% increase from 2015 to 2016 and a further 37.9% increase from 2016 to 2017. Resistance testing demonstrated that penicillinase-sensitive penicillins exhibited an average resistance rate of 87.3%, with gram-negative and gram-positive bacteria showing resistance levels of 90.1% (\u00b18%) and 83.6% (\u00b18%), respectively, indicating a statistically significant association (p&lt;0.05) between high consumption and elevated resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings reveal that AMC in the Dodoma Region is high and is linked to significant resistance against commonly used agents. This study presents a robust method for monitoring AMC and resistance in a resource-efficient manner, offering potential applicability in similar settings across SSA. The data, though representing only a fraction of total antimicrobial use, underscore the urgent need for targeted antimicrobial stewardship interventions, particularly at the primary healthcare level. Future research should further investigate demographic influences and evaluate intervention strategies to mitigate AMR effectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-096682","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:25:34Z","timestamp":1747819534000},"page":"e096682","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective antimicrobial consumption surveillance at health facility level in Dodoma Region, Tanzania"],"prefix":"10.1136","volume":"15","author":[{"given":"Romuald","family":"Mbwasi","sequence":"first","affiliation":[{"name":"St John\u2019s University of Tanzania, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4421-3783","authenticated-orcid":false,"given":"Calvin Andeve","family":"Omolo","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Health Sciences, United States International University, Nairobi, Kenya"},{"name":"Discipline of Pharmaceutics, University of KwaZulu-Natal College of Health Sciences, Durban, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ombaka","sequence":"additional","affiliation":[{"name":"St John\u2019s University of Tanzania, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-0869","authenticated-orcid":false,"given":"Rajabu Mohamedi","family":"Kingo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The University of Dodoma, Dodoma, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mungai","sequence":"additional","affiliation":[{"name":"United States International University, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wiedenmayer","sequence":"additional","affiliation":[{"name":"SCIH, Swiss Tropical and Public Health Institute, Allschwil, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"2025121508182924000_15.5.e096682.1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2305.161556"},{"key":"2025121508182924000_15.5.e096682.2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004371"},{"key":"2025121508182924000_15.5.e096682.3","unstructured":"O\u2019neill JI . Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist 2014. Available: https:\/\/amr-review.org\/sites\/default\/files\/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf"},{"key":"2025121508182924000_15.5.e096682.4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-040218-043954"},{"key":"2025121508182924000_15.5.e096682.5","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.2147\/IDR.S342753","article-title":"Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?","volume":"15","author":"Kariuki","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2025121508182924000_15.5.e096682.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac028"},{"key":"2025121508182924000_15.5.e096682.7","unstructured":"World Health Organization . WHO report on surveillance of antibiotic consumption. Geneva: World Health Organization, 2018."},{"key":"2025121508182924000_15.5.e096682.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233275","article-title":"Antibiotic consumption study in two hospitals in Asmara from 2014 to 2018 using WHO\u2019s defined daily dose (DDD) methodology","volume":"15","author":"Amaha","year":"2020","journal-title":"PLoS One"},{"key":"2025121508182924000_15.5.e096682.9","unstructured":"Sketris IS , Metge CJ , Ross JL , et al . The WHO, Guidelines for ATC classification and DDD assignment 2018. Geneva: World Health Organisation, 2018. Available: https:\/\/www.drugsandalcohol.ie\/29364\/1\/WHO%20Collaborating%20Centre%20for%20Drug%20Statistics%20Methodology.pdf"},{"key":"2025121508182924000_15.5.e096682.10","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S294575"},{"key":"2025121508182924000_15.5.e096682.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025121508182924000_15.5.e096682.12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.cmi.2021.05.037","article-title":"Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries","volume":"27","author":"Lim","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025121508182924000_15.5.e096682.13","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S290835"},{"key":"2025121508182924000_15.5.e096682.14","doi-asserted-by":"crossref","DOI":"10.4102\/ajlm.v12i1.2053","article-title":"Surveillance of antimicrobial resistance in human health in Tanzania: 2016-2021","volume":"12","author":"Camara","year":"2023","journal-title":"Afr J Lab Med"},{"key":"2025121508182924000_15.5.e096682.15","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11081035","article-title":"Prevalence and Predictors of Antibiotic Prescriptions at Primary Healthcare Facilities in the Dodoma Region, Central Tanzania: A Retrospective, Cross-Sectional Study","volume":"11","author":"Mabilika","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2025121508182924000_15.5.e096682.16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.585553","article-title":"National Consumption of Antimicrobials in Tanzania: 2017-2019","volume":"11","author":"Mbwasi","year":"2020","journal-title":"Front Pharmacol"},{"key":"2025121508182924000_15.5.e096682.17","unstructured":"WHO . WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. Geneva: World Health Oganisation, 2018."},{"key":"2025121508182924000_15.5.e096682.18","unstructured":"AMC tool: the antimicrobial consumption tool. n.d. Available: https:\/\/amu-tools.org\/amctool\/amctool.html"},{"key":"2025121508182924000_15.5.e096682.19","article-title":"Measuring Medicine Use: Applying ATC\/DDD Methodology to Real-World Data","volume":"9","author":"Hollingworth","year":"2021","journal-title":"Pharmacy (Basel)"},{"key":"2025121508182924000_15.5.e096682.20","unstructured":"WHO . ATC\/DDD index 2020. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2020. Available: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/methodology"},{"key":"2025121508182924000_15.5.e096682.21","unstructured":"MOHSW . Health information management and financing. Tanzania: Ministry of Health and Social Welfare, 2010."},{"key":"2025121508182924000_15.5.e096682.22","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6947-10-36","article-title":"Bridging the gaps in the Health Management Information System in the context of a changing health sector","volume":"10","author":"Nyamtema","year":"2010","journal-title":"BMC Med Inform Decis Mak"},{"key":"2025121508182924000_15.5.e096682.23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4314\/thrb.v25i2.9","article-title":"Risk factors of delayed developmental milestones among infants attending RCH clinics in Dodoma region. A cross-sectional studydoma region","volume":"25","author":"Gemuhay","year":"2024","journal-title":"Tanzania J Hlth Res"},{"key":"2025121508182924000_15.5.e096682.24","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae081","article-title":"Antibiotic utilization patterns in Tanzania: a retrospective longitudinal study comparing pre- and intra-COVID-19 pandemic era using Tanzania Medicines and Medical Devices Authority data","volume":"6","author":"Sangeda","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2025121508182924000_15.5.e096682.25","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.00454","article-title":"Assessment of Implementation of Antimicrobial Resistance Surveillance and Antimicrobial Stewardship Programs in Tanzanian Health Facilities a Year After Launch of the National Action Plan","volume":"8","author":"Sangeda","year":"2020","journal-title":"Front Public Health"},{"key":"2025121508182924000_15.5.e096682.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042819","article-title":"Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey","volume":"10","author":"Seni","year":"2020","journal-title":"BMJ Open"},{"key":"2025121508182924000_15.5.e096682.27","unstructured":"Ministry of Health and Ministry of Livestock and Fisheries . United Republic of Tanzania: national antimicrobial resistance surveillance framework. 2018:1\u201355."},{"key":"2025121508182924000_15.5.e096682.28","first-page":"675","article-title":"The defined daily dose as a measure of drug consumption in South Africa. A preliminary study","volume":"86","author":"Truter","year":"1996","journal-title":"S Afr Med J"},{"key":"2025121508182924000_15.5.e096682.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70071-4"},{"key":"2025121508182924000_15.5.e096682.30","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-4-45","article-title":"Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania","volume":"4","author":"Blomberg","year":"2004","journal-title":"BMC Public Health"},{"key":"2025121508182924000_15.5.e096682.31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.33393\/dti.2022.2476","article-title":"Understanding the environmental drivers of clinical azole resistance in Aspergillus species","volume":"16","author":"Sen","year":"2022","journal-title":"Drug Target Insights"},{"key":"2025121508182924000_15.5.e096682.32","unstructured":"World Health Organization . Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2017-2018. 2018."},{"key":"2025121508182924000_15.5.e096682.33","unstructured":"European Centre for Disease Prevention and Control . Annual epidemiological report for 2017: antimicrobial consumption. Stockholm: European Centre for Disease Prevention and Control, 2017."},{"key":"2025121508182924000_15.5.e096682.34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.639207","article-title":"Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe","volume":"12","author":"Robertson","year":"2021","journal-title":"Front Pharmacol"},{"key":"2025121508182924000_15.5.e096682.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717295115"},{"key":"2025121508182924000_15.5.e096682.36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmi.2016.11.013","article-title":"Amoxicillin dosing recommendations are very different in European countries: a cross-sectional survey","volume":"23","author":"Pulcini","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2025121508182924000_15.5.e096682.37","doi-asserted-by":"crossref","first-page":"111893","DOI":"10.1016\/j.jphotobiol.2020.111893","article-title":"Global priority multidrug-resistant pathogens do not resist photodynamic therapy","volume":"208","author":"Sabino","year":"2020","journal-title":"J Photochem Photobiol B"},{"key":"2025121508182924000_15.5.e096682.38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-191"},{"key":"2025121508182924000_15.5.e096682.39","doi-asserted-by":"publisher","DOI":"10.4103\/jms.jms_25_17"},{"key":"2025121508182924000_15.5.e096682.40","unstructured":"Kabanangi FJ . Bacterial causes and antibiotic susceptibility patterns of aerobic isolates from burn wound infections in Dar es Salaam, Tanzania. Muhimbili University of Health and Allied Sciences, 2017. Available: http:\/\/dpsvr.muhas.ac.tz:8080\/xmlui\/handle\/123456789\/2087"},{"key":"2025121508182924000_15.5.e096682.41","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061340","article-title":"Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"2025121508182924000_15.5.e096682.42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4314\/thrb.v21i2.7","article-title":"Ceftriaxone prescribing and resistance pattern at a national hospital in Tanzania","volume":"21","author":"Sasi","year":"2019","journal-title":"Tanzan J Health Res"},{"key":"2025121508182924000_15.5.e096682.43","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/IDR.S250158","article-title":"The Existence of High Bacterial Resistance to Some Reserved Antibiotics in Tertiary Hospitals in Tanzania: A Call to Revisit Their Use","volume":"13","author":"Mikomangwa","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2025121508182924000_15.5.e096682.44","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i939","article-title":"Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis","volume":"352","author":"Bryce","year":"2016","journal-title":"BMJ"},{"key":"2025121508182924000_15.5.e096682.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2713-1","article-title":"Antimicrobial resistance in Africa: a systematic review","volume":"17","author":"Tadesse","year":"2017","journal-title":"BMC Infect Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-096682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:18:42Z","timestamp":1765815522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-096682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,21]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjopen-2024-096682"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-096682","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}